R Ruda, L Bello, H Duffau, R Soffietti - Neuro-oncology, 2012 - academic.oup.com
Seizures represent a common symptom in low-grade gliomas; when uncontrolled, they significantly contribute to patient morbidity and negatively impact quality of life. Tumor …
Many patients with medically refractory epilepsy now undergo successful surgery based on noninvasive diagnostic information, but intracranial electroencephalography (IEEG) …
DJ Englot, MS Berger, NM Barbaro, EF Chang - Epilepsia, 2012 - Wiley Online Library
Summary Purpose: Gangliogliomas (GGs) and dysembryoplastic neuroepithelial tumors (DNETs) are low‐grade brain tumors of glioneuronal origin that commonly present with …
DJ Englot, MS Berger, NM Barbaro, EF Chang - Journal of neurosurgery, 2011 - thejns.org
Object Seizures are the most frequent presenting symptom in patients with low-grade gliomas (LGGs), and significantly influence quality of life if they are uncontrolled. Achieving …
Epilepsy surgery is highly successful in achieving seizure freedom in carefully selected children with drug‐resistant focal epilepsy. Advances in technology have aided presurgical …
Epilepsy is a debilitating neurological disorder affecting approximately 1% of the world's population. Drug-resistant focal epilepsies are potentially surgically remediable. Although …
DJ Englot, SJ Han, MS Berger, NM Barbaro… - Neurosurgery, 2012 - journals.lww.com
BACKGROUND: Achieving seizure control in patients with low-grade temporal lobe gliomas or glioneuronal tumors remains highly underappreciated, because seizures are the most …
M Giulioni, G Marucci, M Martinoni… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Long-term epilepsy associated tumors (LEAT) represent a well known cause of focal epilepsies. Glioneuronal tumors are the most frequent histological type consisting of a …
MS Perry, M Duchowny - Epilepsia, 2013 - Wiley Online Library
Nearly one third of patients with epilepsy become medically intractable, and the likelihood of achieving seizure freedom decreases with each additional medication trial. For …